Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Toyama licenses neuroprotective compound from Senju

Oct. 22, 1998

Lomerizine, a new antimigraine agent, compared to flunarizine in rats

Oct. 22, 1998

Dopaminergic and serotonergic agents synthesized at Lundbeck

Oct. 22, 1998

NOS inhibitors developed at Chugai reportedly useful for cerebrovascular disorders

Oct. 22, 1998

Pramipexole improves rest tremor in Parkinson's disease

Oct. 22, 1998

Linopirdine analogue proves to be more potent neurotransmitter release enhancer

Oct. 21, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

MorphiDex NDA accepted for FDA review

Oct. 21, 1998

Potent CRF1 receptor antagonists and their use described by Yoshitomi

Oct. 21, 1998

Phase I trial for Anergen multiple sclerosis compound demonstrates safety

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...